Publication | Open Access
Treatment of atrial fibrillation with doxapram: TASK-1 potassium channel inhibition as a novel pharmacological strategy
48
Citations
35
References
2021
Year
Repurposing doxapram might yield a promising new antiarrhythmic drug to treat AF in patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1